Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin

ConditionsSinus Perforation Dental Implant Failure Nos

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-40

SponsorKafrelsheikh University

About this trial

This research aimed to evaluate the effect of an autologous Alb-PRF on bone regeneration after lateral sinus lifting via 3D volumetric analysis. The null hypothesis of this research was that there would be no significant difference between the group that would be treated by lateral sinus lift and Alb-PRF application and that would be treated by lateral sinus lift with bone graft for bone regeneration.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Males and females ≥18 years of age.

ASA I and ASA II.

Patients having partial edentulism in the posterior region of the maxilla.

Edentulous sites consist of native non augmented bone.

Disqualifiers

- Patients with uncontrolled systemic diseases.

History of chronic maxillary sinus pathology.

Heavy smokers or patients with poor oral hygiene.

Trial design

Design model

Parallel

Treatments tested in this trial

Guided Lateral Sinus Lifting with bone graft
Procedure/Surgery
Lateral window was done using surgical guide for placement of fifteen implants in posterior edentulous maxillary regions. Then bone graft only will be used.
Guided Lateral Sinus Lifting with Autologous Serum Albumin/Platelet-Rich Fibrin
Procedure/Surgery
Lateral window was done using surgical guide for placement of fifteen implants in posterior edentulous maxillary regions. Then an autologous Alb-PRF only will be used
Guided Lateral Sinus Lifting with sticky bone
Procedure/Surgery
Lateral window was done using surgical guide for placement of fifteen implants in posterior edentulous maxillary regions. Then sticky bone \[bone graft with Alb-PRF\] only will be used

Treatment groups

45 Participants

are divided into 3 treatment groups

Group A: Group IExperimental treatment 1 intervention

Group B: Group IIExperimental treatment 1 intervention

Group C: Group IIIExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Implant stability

using implant stability quotient device

Time frame

12-months

Secondary outcomes

Vertical bone height gain

assessed by CBCT.by measuring the distance from alveolar crest to sinus floor

Time frame

12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kafrelsheikh University

Lead sponsor

Source ClinicalTrials.gov

Apply now